CREATE Medicines strengthens executive team with appointment of veteran biopharma leader Allan L. Shaw as CFO and CBO October 9, 2025 Categories: Health Care Tags: CREATE Medicines
Myeloid Therapeutics rebrands as CREATE Medicines, focused on transforming immunotherapy through RNA-based in vivo multi-immune programming October 9, 2025 Categories: Health Care Tags: CREATE Medicines
